BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15304050)

  • 1. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
    Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
    J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring plasminogen activator inhibitor activity in plasma by two enzymatic assays.
    Chiu WC; Gann DS; Darlington DN
    J Biochem Biophys Methods; 2000 Sep; 45(2):127-40. PubMed ID: 10989129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19.
    Yatsenko T; Rios R; Nogueira T; Takahashi S; Tabe Y; Naito T; Takahashi K; Hattori K; Heissig B
    Front Immunol; 2023; 14():1299792. PubMed ID: 38313435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-acting PAI-1 inhibitor reduces thrombus formation.
    Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
    Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin.
    Han T; Zhang G; Yan D; Yang H; Ma T; Ye Z
    Fitoterapia; 2016 Sep; 113():117-22. PubMed ID: 27476618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
    Brown JM; Watanabe K; Cohen RL; Chambers DA
    Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.
    Chandler WL; Levy WC; Stratton JR
    Circulation; 1995 Nov; 92(10):2984-94. PubMed ID: 7586269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
    Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
    Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of P2Y
    Bondu V; Bitting C; Poland VL; Hanson JA; Harkins MS; Lathrop S; Nolte KB; Lawrence DA; Buranda T
    Front Cell Infect Microbiol; 2018; 8():169. PubMed ID: 29930915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.
    Gong L; Liu M; Zeng T; Shi X; Yuan C; Andreasen PA; Huang M
    J Biol Chem; 2015 Oct; 290(43):25795-804. PubMed ID: 26324706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.
    Sherman PM; Lawrence DA; Verhamme IM; Paielli D; Shore JD; Ginsburg D
    J Biol Chem; 1995 Apr; 270(16):9301-6. PubMed ID: 7721851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; BrĂ¼nner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.